Dickensian winter disappears

OXFORD - London biotech stocks, like their U.S. counterparts, have seen massive price increases since mid-October, with BioCentury's London Index rising 132 percent over the period. Various fund managers see little evidence that biotech enthusiasm will slow down any time soon.

As in the U.S., internal and

Read the full 464 word article

How to gain access

Continue reading with a
two-week free trial.